Mount Sinai Health System account plan
Integrated Health Care Provider
At a glance
Mount Sinai Health System is a New York not-for-profit academic health system: seven hospitals, 48,000 caregivers and $12.76bn of 2025 revenue.
Mount Sinai Health System, Inc. is a New York not-for-profit integrated academic health system providing patient care, teaching and research in New York City and Nassau County. It runs seven hospitals, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, Mount Sinai Brooklyn, New York Eye and Ear Infirmary and South Nassau Communities Hospital, more than 400 outpatient practices and the Icahn School of Medicine at Mount Sinai. In FY2025 total operating revenue was $12.76bn (2024: $11.85bn), income from operations swung to $36.6m from a $(265.4)m loss, and the excess of revenue over expenses was $259.8m. It has 48,000 caregivers, including more than 9,000 physicians and 8,500 nurses, and served over 1.3 million unique patients in 2024. Brendan G. Carr, MD, is CEO.
Business units
Mount Sinai Hospitals Group (hospitals)
about 72% of FY2025 operating revenue ($9.16bn of patient service revenue)The hospitals: The Mount Sinai Hospital with Mount Sinai Queens, Beth Israel (Mount Sinai Brooklyn, Union Square, Behavioral Health Center), St. Luke's-Roosevelt (Mount Sinai West and Morningside), New York Eye and Ear Infirmary and South Nassau Communities Hospital. Outpatient revenue ($4.77bn) now exceeds inpatient ($4.39bn); Beth Israel's 16th Street campus closed on April 9, 2025.
Icahn School of Medicine at Mount Sinai
Teaching and research institution with faculty and community physician practice plans, ranked #11 nationally among medical schools for NIH funding. Federal grants and contracts revenue was $699.0m in 2025, and it runs the professional services of NYC Health + Hospitals' Elmhurst and Queens hospitals ($363.1m of affiliation revenue).
Pharmacy
about 9% of FY2025 operating revenue ($1.12bn of pharmacy sales)Sales of pharmaceuticals and related products, the largest single line of other revenue, up from $871.9m in 2024.
The Mount Sinai Medical Center (pooled investments)
Holds the pooled investment portfolio for the System entities ($2.33bn at Dec 31, 2025); investment income in operating revenue was $341.0m.
Real estate entities
Real estate holdings and related services, including 8 East 102nd Street Manager, LLC and MSMC Realty Corporation, with rental income of $72.6m.
Strategic priorities
- One Mount Sinai transformation
- A system transformation unifying operations and technology and streamlining governance, with three goals: coordinated patient care, advancing research and "ensuring long-term financial sustainability".
- Revenue growth levers
- The CFO names 340B expansion, economies of scale, new revenue streams, outpatient expansion, more transplant and cardiac cases, and commercial volume in women, children and orthopaedics.
- Revenue cycle improvement
- A Chief Revenue Officer and a Chief Integrity Officer were appointed to improve charge capture, coding and documentation, appeals and denial prevention, supported by revenue cycle automation.
- AI and automation that augment staff
- The CEO aims over the next five to ten years to "recalibrate over time what we can and should hand off to automated systems", with AI already used for ambient listening transcription and patient digital touchpoints.
- Centralised finance and systems
- Stabilise Oracle Cloud ERP and Oracle FCCS and move to a more centralised finance operating model after repeat auditor findings on financial close and reporting.
Investments and deals
- Technology platforms
- Targeted investments in telehealth, revenue cycle automation, EPIC electronic health records, Oracle ERP and clinical infrastructure; capitalised internal-use software reached $998.6m gross at year-end 2025.
- Capital projects
- Acquisition of property, plant and equipment was $476.2m in 2025 (2024: $590.1m), with construction in progress of $472.0m and about $244.6m of contractually committed capital projects.
- August 2025 refinancing
- DASNY issued $248.8m of MSH Series 2025 tax-exempt bonds to refinance Series 2017 bonds and fund projects at MSH, SLR and SNCH; MSH tendered about $341.9m of taxable bonds, producing a gain of about $99.6m.
Challenges and risks
- Medicaid cuts and government payment risk
- The CFO said Medicaid reconciliation cuts would cost Mount Sinai about $200 million-$300 million per year as drafted, and the statements warn legislation could significantly reduce payment and enrollment rates.
- Thin operating margin and credit rating
- Income from operations was only $36.6m on $12.76bn of revenue in 2025 after a loss in 2024, and Moody's downgraded the system to Baa3.
- Financial reporting control weaknesses
- Ernst & Young flagged repeat significant deficiencies in financial close and consolidated reporting and a material weakness in suspension-and-debarment screening for research vendors.
- Payer and labour concentration
- A significant payer left the network for some services after year-end until an April 2026 agreement, and about 49% of employees are union members.
- Cybersecurity
- Ransomware and connected medical devices are named cyber risks, handled with the Chief Technology Officer through drills, HIPAA compliance and staff education.
What leadership says
“We know that it's our job to invent the future of health care delivery and we pursue that daily in our clinical work, our research and, frankly, our back-office functions as well.”
“We are not going to instantly replace everyone in health care – but our jobs are going to change.”
“Technology is a strategic driver of financial performance, patient experience, and operational efficiency.”
“space utilization, lease management, investment tools, capital and equipment modernization – anything to generate supplemental revenue outside the traditional ways”
Where a supplier can help
- Revenue cycle and denial prevention
- The new Chief Revenue Officer's remit on charge capture, coding, appeals and denials, together with revenue cycle automation, is a direct entry point for coding, denial management and payer-contracting tools.
- Finance systems and controls
- Repeat auditor findings on financial close and the Oracle ERP and FCCS stabilisation create needs for ERP consulting, close automation and vendor-screening compliance tools.
- Clinical and administrative AI
- Leadership wants AI to extend the workforce in clinical and back-office work, building on ambient transcription and virtual specialists, which suits AI documentation, automation and telehealth vendors.
- Cybersecurity for connected devices
- Ransomware and connected medical devices are named risks, so medical device security and HIPAA training suppliers address a stated priority.
- Outpatient and specialty growth
- Outpatient expansion and growth in transplant, cardiac, women's, children's and orthopaedic volume call for ambulatory site development, scheduling and patient access solutions.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Mount Sinai Health System?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Mount Sinai Health System, Inc. Consolidated Financial Statements and Supplementary Information, Years Ended December 31, 2025 and 2024 (with Uniform Guidance audit reports)
- Mount Sinai Health System, Inc. (MSHS) is a New York not-for-profit integrated academic health system in New York City and Nassau County: sole member of Mount Sinai Hospitals Group (MSHG), which holds The Mount Sinai Hospital (incl. Mount Sinai Queens), Beth Israel Medical Center (Mount Sinai Brooklyn, Union Square, Behavioral Health Center, Phillips School of Nursing), St. Luke's-Roosevelt (Mount Sinai West, Mount Sinai Morningside), New York Eye and Ear Infirmary and South Nassau Communities Hospital, plus the Icahn School of Medicine at Mount Sinai (ISMMS).
- FY2025 (year to Dec 31, 2025): total operating revenue $12.76bn (2024: $11.85bn); patient service revenue $9.16bn, other revenue $3.61bn. Income from operations swung to $36.6m from a $(265.4)m loss in 2024; excess of revenue over expenses $259.8m (2024: $86.5m), helped by a $99.6m gain on retirement of bonds.
- Payer mix of patient revenue: commercial and managed care $2.95bn, Medicare $2.84bn, Blue Cross $1.64bn, Medicaid $1.45bn, self-pay $272.4m; outpatient ($4.77bn) now exceeds inpatient ($4.39bn).
- Other revenue drivers: pharmacy sales $1.12bn (2024: $871.9m), federal grants and contracts $699.0m, NYC Health + Hospitals affiliation revenue $363.1m, investment income $341.0m, royalty revenue $96.7m; no FEMA revenue in 2025 vs $183.6m in 2024.
- Cost base: salaries and wages $6.15bn, supplies and other $4.38bn; 49% of employees are unionised, about 25% of covered employees under a contract expiring before Dec 31, 2026.
- Balance sheet: total assets $14.15bn, cash $1.37bn, long-term debt $3.38bn net of current portion; capex (acquisition of PP&E) $476.2m vs $590.1m; capitalised internal-use software $998.6m; Aug 2025 refinancing issued $248.8m of MSH Series 2025 bonds and tendered $341.9m of taxable bonds.
- Events: Beth Israel's 16th Street campus closed on April 9, 2025; after year-end a significant payer left the network for some services, with a new in-network agreement reached in April 2026; FEMA recognised a further $86.1m in February 2026.
- Auditor (Ernst & Young) flagged repeat significant deficiencies in the financial close and consolidated reporting (Oracle ERP / FCCS stabilisation) and a material weakness in suspension-and-debarment screening for the Research and Development Cluster.
- The Future Of Healthcare Delivery: An Interview with Brendan G. Carr, MD, MS, Chief Executive Officer, Mount Sinai Health System (LEADERS)
- Brendan G. Carr, MD, CEO of Mount Sinai Health System, interviewed by LEADERS magazine (July 2026 issue).
- Institution brief: 48,000 caregivers including more than 9,000 physicians and 8,500 nurses, seven hospitals, more than 400 outpatient practices and 600 research and clinical labs; ISMMS ranks #11 nationally for NIH funding.
- Innovation framing: "Innovation just means finding creative new ways to improve human health"; the tagline is "We Find a Way", applied to clinical work, research and back-office functions.
- On AI: refuses the "mass unemployment" framing; the goal over five to ten years is to "recalibrate over time what we can and should hand off to automated systems".
- Mount Sinai is "building an ecosystem and harnessing technology to automate and democratize health care where possible", freeing people for what only humans can do.
- Education: medical, biomedical and nursing curricula must evolve because facts and their synthesis "will be commoditized" by AI; what remains is the human part.
- Cites tele-medicine and virtual specialists across the system for ED and ICU consultations as delivery innovation.
- One Mount Sinai: An Interview with Vincent Tammaro, Executive Vice President and Chief Financial Officer, Mount Sinai Health System (LEADERS)
- Vincent Tammaro, EVP and CFO of Mount Sinai Health System (formerly CFO of Ohio State Wexner Medical Center and of Yale-New Haven Health), interviewed by LEADERS magazine (July 2025 issue).
- Leads the financial side of the "One Mount Sinai" (OMS) transformation, with three goals: coordinated patient care, research, and "long-term financial sustainability".
- Headwinds he names: the Mount Sinai Beth Israel campus closure, a Moody's downgrade to Baa3, and Medicaid reconciliation cuts that would cost Mount Sinai about $200 million-$300 million per year as drafted.
- Growth levers: 340B expansion, economies of scale, new revenue streams, outpatient expansion, more transplant/cardiac cases, commercial volume in women, children and ortho.
- Technology investments: telehealth, revenue cycle automation, EPIC EHR, Oracle ERP and clinical infrastructure; a Chief Revenue Officer and a Chief Integrity Officer were appointed for charge capture, coding, appeals and denial prevention.
- Cybersecurity is a priority (ransomware, connected medical devices), with the CTO; AI is used for ambient listening transcription and personalised digital touchpoints.
- Scale cited: about 48,000 employees, over 1.3 million unique patients in 2024, nearly $900 million of uncompensated care a year, over $900 million of supplies bought from New York State vendors (22 percent of all supplies).
Questions about Mount Sinai Health System
What does Mount Sinai Health System do?
It is a not-for-profit academic health system in New York City and Nassau County providing patient care, teaching and research through seven hospitals, more than 400 outpatient practices and the Icahn School of Medicine at Mount Sinai.
What is Mount Sinai Health System's revenue?
Total operating revenue was $12.76bn in FY2025, up from $11.85bn, with income from operations of $36.6m.
How many employees does Mount Sinai Health System have?
About 48,000 caregivers, including more than 9,000 physicians and 8,500 nurses.
Who leads Mount Sinai Health System?
Brendan G. Carr, MD, an emergency physician and health-policy researcher, is CEO; Vincent Tammaro is Executive Vice President and CFO.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)